Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), une société biopharmaceutique, a annoncé lundi que la Food and Drug Administration (FDA) américaine a approuvé une mise à jour des informations de ...
La FDA accepte la demande supplémentaire de nouveau médicament d'Agios pour le traitement de la thalassémie PYRUKYND ...
Patients with SLE have a higher prevalence of periodontal disease 5 compared with systemically healthy patients. The factors that correlate with SLE and periodontal diseases have not been fully ...
BofA Securities est positif et recommande le titre à l'achat. L'objectif de cours est abaissé de 60 USD à 55 USD.
The authors show that increased pyruvate import into the mitochondria in liver-like cells and in primary hepatocytes drives gluconeogenesis but reduces cellular amino acid production, suppressing ...
-- Agios Pharmaceuticals a déclaré mercredi que la Food and Drug Administration des États-Unis a accepté d'examiner sa ...
PARIS — Marine Le Pen has always walked a tightrope between being the outsider, intent on taking a wrecking ball to the French establishment, and cultivating a more mainstream image to win ...
Le chef de l’opposition a réitéré qu’il n’exclut pas de riposter à Donald Trump avec des tarifs douaniers. Le gouvernement n’a pas pris de décision sur des mesures de rétorsion, mais ...
PARIS, Dec 18 (Reuters) - French far-right leader Marine Le Pen said on Wednesday that she was preparing for an early presidential election, saying President Emmanuel Macron's time in office was ...
PARIS — French far-right leader Marine Le Pen said Wednesday she’s getting ready to run for an early presidential election, predicting that Emmanuel Macron’s era as French president will be over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback